Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.

Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.

BACKGROUND: The cationic lipid Genzyme lipid (GL) 67 is the current "gold-standard" for in vivo lung gene transfer. Here, we assessed, if GL67 mediated uptake of siRNAs and asODNs into airway epithelium in vivo. METHODS: Anti-lacZ and ENaC (epithelial sodium channel) siRNA and asODN were...

Bibliografiset tiedot
Päätekijät:	Griesenbach, U, Kitson, C, Escudero Garcia, S, Farley, R, Singh, C, Somerton, L, Painter, H, Smith, R, Gill, DR, Hyde, S, Chow, Y, Hu, J, Gray, M, Edbrooke, M, Ogilvie, V, MacGregor, G, Scheule, R, Cheng, S, Caplen, N, Alton, E
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

LacZ siRNA and antisense DNA decrease beta-galactosidase mRNA but not protein expression in the airways of K18-lacZ transgenic mice
Tekijä: Griesenbach, U, et al.
Julkaistu: (2004)

Down-regulation of the epithelial sodium channel ENaC through antisense oligonucleotides
Tekijä: Griesenbach, U, et al.
Julkaistu: (2004)

Gene silencing through RNA interference and antisense strategies in the lung
Tekijä: Griesenbach, U, et al.
Julkaistu: (2003)

Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA
Tekijä: Järver, P, et al.
Julkaistu: (2012)

Selective targeting of MYC by antisense oligonucleotides
Tekijä: Gill, Taylor Elizabeth
Julkaistu: (2018)

Towards understanding and applications of antisense oligonucleotides
Tekijä: Nguyen, Le Tuan Anh
Julkaistu: (2020)

Wrangling RNA: Antisense oligonucleotides for neurological disorders
Tekijä: Talbot, K, et al.
Julkaistu: (2019)

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
Tekijä: Betts, C, et al.
Julkaistu: (2012)

Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
Tekijä: Southern, E, et al.
Julkaistu: (1997)

Selecting effective antisense reagents on combinatorial oligonucleotide arrays.
Tekijä: Milner, N, et al.
Julkaistu: (1997)

OPTIMIZING THE DESIGN OF ANTISENSE THERAPEUTICS USING OLIGONUCLEOTIDE ARRAYS
Tekijä: Casegreen, S, et al.
Julkaistu: (1994)

Engineering antisense oligonucleotides as a tool in synthetic biology.
Tekijä: Chng, Si Hui.
Julkaistu: (2013)

Quantitative fluorescence imaging of antisense oligonucleotide mediated knockdown
Tekijä: Chan, Nicholas Zhen Woon
Julkaistu: (2024)

Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Tekijä: Rinaldi, C, et al.
Julkaistu: (2017)

Improving Cardiac Delivery of Antisense Oligonucleotides with Peptidomimetic Targeting Agents
Tekijä: Antilla, Sarah An-ning
Julkaistu: (2023)

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
Tekijä: Gill, Taylor, et al.
Julkaistu: (2024)

Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides
Tekijä: Wolfe, Justin, et al.
Julkaistu: (2020)

Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
Tekijä: Koo, T, et al.
Julkaistu: (2013)

Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
Tekijä: Andaloussi, S, et al.
Julkaistu: (2011)

Peptide-mediated delivery of antisense oligonucleotides and chemotherapeutics across biological barriers
Tekijä: Fadzen, Colin MacLaine
Julkaistu: (2018)

PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy.
Tekijä: Hammond, S, et al.
Julkaistu: (2010)

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
Tekijä: Xue, K, et al.
Julkaistu: (2020)

Thermodynamics and kinetics of antisense oligonucleotide hybridization to a structured mRNA target
Tekijä: Walton, S. Patrick (Stephen Patrick), 1973-
Julkaistu: (2008)

New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy.
Tekijä: Aoki, Y, et al.
Julkaistu: (2012)

Development of antisense oligonucleotides : a cellular model for enhancing receptor-mediated uptake
Tekijä: Iyer, Vaishnavi Srinivasan
Julkaistu: (2017)

Modulation of interleukin 1 beta gene expression using antisense phosphorothioate oligonucleotides.
Tekijä: Manson, J, et al.
Julkaistu: (1990)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
Tekijä: Davies, J, et al.
Julkaistu: (2011)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
Tekijä: Davies, G, et al.
Julkaistu: (2011)

Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.
Tekijä: MacKellar, C, et al.
Julkaistu: (1992)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
Tekijä: Wood, M, et al.
Julkaistu: (2017)

Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
Tekijä: Krainer, Adrian R., et al.
Julkaistu: (2011)

The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways.
Tekijä: Griesenbach, U, et al.
Julkaistu: (2010)

Inefficiencies on Linking Decisions.
Tekijä: Hortala-Vallve, R
Julkaistu: (2007)

Inefficiencies on linking decisions
Tekijä: Hortala-Vallve, R
Julkaistu: (2007)

Development of ratiometric fluorescent pH nanoprobe to study endocytic uptake pathways of antisense oligonucleotides
Tekijä: Liew, Donn Hou Feng
Julkaistu: (2021)

Evaluation of cell-penetrating peptide delivery of antisense oligonucleotides for therapeutic efficacy in spinal muscular atrophy
Tekijä: Hammond, S, et al.
Julkaistu: (2019)

Synthesis and biophysical properties of carbamate-locked nucleic acid (LNA) oligonucleotides with potential antisense applications
Tekijä: Thorpe, C, et al.
Julkaistu: (2019)

Challenges for antisense oligonucleotide-based therapeutics, in particular for exon 51-skipping in Duchenne muscular dystrophy
Tekijä: Aoki, Y, et al.
Julkaistu: (2011)

Limitations of the murine nose in the development of nonviral airway gene transfer.
Tekijä: Griesenbach, U, et al.
Julkaistu: (2010)

In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
Tekijä: Wang, Q, et al.
Julkaistu: (2010)